diphlorethohydroxycarmalol and Non-alcoholic-Fatty-Liver-Disease

diphlorethohydroxycarmalol has been researched along with Non-alcoholic-Fatty-Liver-Disease* in 1 studies

1 other study(ies) available for diphlorethohydroxycarmalol and Non-alcoholic-Fatty-Liver-Disease

Article	Year
Diphlorethohydroxycarmalol Attenuates Palmitate-Induced Hepatic Lipogenesis and Inflammation. Marine drugs, 2020, Sep-18, Volume: 18, Issue:9 Topics: Hep G2 Cells; Heterocyclic Compounds, 3-Ring; Humans; Inflammation; Lipogenesis; Liver; Non-alcoholic Fatty Liver Disease; Palmitates; Phaeophyceae	2020